長澤逸人 (Hayato Nagasawa) - マイポータル

基本情報

J-GLOBAL ID: 200901034816692580
researchmap会員ID: 1000356104

経歴

MISC

Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: A report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs

Masayoshi Harigai, Akito Takamura, Tatsuya Atsumi, Makoto Dohi, Shintaro Hirata, Hideto Kameda, Hayato Nagasawa, Yohei Seto, Takao Koike, Nobuyuki Miyasaka

Modern Rheumatology 23(2) 284-296 2013年3月
Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs.A retrospective study of serum・・・

Takamura A, Hirata S, Nagasawa H, Kameda H, Seto Y, Atsumi T, Dohi M, Koike T, Miyasaka N, Harigai M

Mod Rheumatol 23(2) 297-303 2013年3月
Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis

Eiko Nishi, Hideto Kameda, Hiroe Ogawa, Hayato Nagasawa, Hirofumi Takei, Ayumi Okuyama, Takahiko Kurasawa, Tsuneo Kondo, Koji Nishimura, Yuichiro Shirai …

MODERN RHEUMATOLOGY 23(1) 97-103 2013年1月
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules

Ryoko Sakai, Michi Tanaka, Toshihiro Nanki, Kaori Watanabe, Hayato Yamazaki, Ryuji Koike, Hayato Nagasawa, Koichi Amano, Kazuyoshi Saito, Yoshiya Tanaka …

ANNALS OF THE RHEUMATIC DISEASES 71(11) 1820-1826 2012年11月
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.

Michi Tanaka, Ryoko Sakai, Ryuji Koike, Yukiko Komano, Toshihiro Nanki, Fumikazu Sakai, Haruhito Sugiyama, Hidekazu Matsushima, Toshihisa Kojima, Shuji Ohta …

Modern rheumatology 22(6) 849-858 2012年11月
Time-dependent increased risk for serious infection from continuous use of TNF antagonists during three years in rheumatoid arthritis patients

Sakai R, Komano Y, Tanaka M, Nanki T, Koike R, Nagasawa H, Amano K, Nakajima A, Atsumi T, Koike T …

Arthritis Care Res 64(8) 1125-1134 2012年8月
Clinical Significance of Cartilage Biomarkers for Monitoring Structural Joint Damage in Rheumatoid Arthritis Patients Treated with Anti-TNF Therapy

Yasuo Niki, Tsutomu Takeuchi, Masanori Nakayama, Hayato Nagasawa, Takahiko Kurasawa, Harumoto Yamada, Yoshiaki Toyama, Takeshi Miyamoto

PLOS ONE 7(5) e37447 2012年5月
Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept

Yoshiya Tanaka, Hisashi Yamanaka, Kazuyoshi Saito, Shigeru Iwata, Ippei Miyagawa, Yohei Seto, Shigeki Momohara, Hayato Nagasawa, Hideto Kameda, Yuko Kaneko …

MODERN RHEUMATOLOGY 22(2) 186-194 2012年4月
Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis

Michihide Tokuhira, Reiko Watanabe, Tomoe Nemoto, Morihiko Sagawa, Tatsuki Tomikawa, Jun-ichi Tamaru, Shinji Itoyama, Hayato Nagasawa, Koichi Amano, Hideto Kameda …

LEUKEMIA & LYMPHOMA 53(4) 616-623 2012年4月
Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review

Ryota Sakai, Hayato Nagasawa, Eiko Nishi, Ayumi Okuyama, Hirofumi Takei, Takahiko Kurasawa, Tsuneo Kondo, Koji Nishimura, Yuichiro Shirai, Tatsuya Ito …

CLINICAL RHEUMATOLOGY 31(3) 569-574 2012年3月
A Case of Multiple Giant Coronary Aneurysms and Abdominal Aortic Aneurysm Coexisting with IgG4-related Disease

Hirofumi Takei, Hayato Nagasawa, Ryota Sakai, Koji Nishimura, Takahiko Kurasawa, Ayumi Okuyama, Eiko Nishi, Yuichiro Shirai, Tsuneo Kondo, Hiroe Ogawa …

INTERNAL MEDICINE 51(8) 963-967 2012年
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients-REACTION 52-week study

Tsutomu Takeuchi, Yoshiya Tanaka, Koichi Amano, Daisuke Hoshi, Masao Nawata, Hayato Nagasawa, Eri Sato, Kazuyoshi Saito, Yuko Kaneko, Shunsuke Fukuyo …

RHEUMATOLOGY 50(10) 1908-1915 2011年10月
Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus

Katsuya Suzuki, Hideto Kameda, Koichi Amano, Hayato Nagasawa, Hirofumi Takei, Eiko Nishi, Ayumi Okuyama, Kensei Tsuzaka, Tsutomu Takeuchi

RHEUMATOLOGY INTERNATIONAL 31(6) 757-763 2011年6月
Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus

Katsuya Suzuki, Hideto Kameda, Koichi Amano, Hayato Nagasawa, Hirofumi Takei, Eiko Nishi, Ayumi Okuyama, Kensei Tsuzaka, Tsutomu Takeuchi

RHEUMATOLOGY INTERNATIONAL 31(6) 757-763 2011年6月
Fcγreceptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis

Okuyama A, Nagasawa H, Suzuki K, Kameda H, Kondo H, Amano K, Takeuchi T

Ann Rheum Dis 70(2) 299-304 2011年2月
IgG4-positive multi-organ lymphoproliferative syndrome manifesting as chronic symmetrical sclerosing dacryo-sialadenitis with subsequent secondary portal hypertension and remarkable IgG4-linked IL-4 elevation

Katsuya Suzuki, Jun-ichi Tamaru, Ayumi Okuyama, Hideto Kameda, Koichi Amano, Hayato Nagasawa, Eiko Nishi, Keiko Yoshimoto, Yumiko Setoyama, Keiko Kaneko …

RHEUMATOLOGY 49(9) 1789-1791 2010年9月
Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis

Hayato Nagasawa, Hideto Kameda, Naoya Sekiguchi, Koichi Amano, Tsutomu Takeuchi

MODERN RHEUMATOLOGY 20(4) 337-342 2010年8月
Normalisation of physical function by infliximab in patients with RA: factors associated with normal physical function

H. Nagasawa, H. Kameda, N. Sekiguchi, K. Ammo, T. Takeuchi

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 28(3) 365-372 2010年5月
Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells

Motohiko Tanino, Ryo Matoba, Seiji Nakamura, Hideto Kameda, Kouichi Amano, Toshitsugu Okayama, Hayato Nagasawa, Katsuya Suzuki, Kenichi Matsubara, Tsutomu Takeuchi

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 387(2) 261-265 2009年9月
TNF阻害薬の関節破壊抑制効果

長澤逸人, 竹内勤

CLINICAL CALCIUM 19(3) 124-132 2009年3月

もっとみる

書籍等出版物

エタネルセプトの基本情報と使い方抗リウマチ薬Q＆Ａ

日本医学出版（東京） 2005年12月
エタネルセプトの副作用の特徴抗リウマチ薬Q＆Ａ

日本医学出版（東京） 2005年12月
エタネルセプトの臨床効果の特徴抗リウマチ薬Q＆Ａ

日本医学出版（東京） 2005年12月

講演・口頭発表等

The efficacy of tocilizumab for adult-onset Still's disease

The 15th Congress of Asisa Pacific League of Associations for Rheumatology 2012年
THE ADDITION OF ANOTHER DISEASE-MODIFYING ANTI-RHEUMATIC DRUG TO METHOTREXATE IN PLACE OF INFLIXIMAB IMPROVES THE RATE OF INFLIXIMAB-FREE SUSTAINED REMISSION:RESULTS FROM THE BuSHIDO TRIAL

EULAR 2012年
心アミロイドーシスを合併した強皮症の一例

第49回関東リウマチ研究会 2008年
Infliximab投与によるHAQの改善および関節破壊阻止

第105回日本内科学会講演会 2008年
Infliximab投与によるHAQの改善および関節破壊阻止

第52回日本リウマチ学会総会・学術集会 2008年